Naina Zeman
Vice President, Investor Relations
Replay available
Novavax, Inc. (NASDAQ: NVAX) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.

Vice President, Investor Relations
President & Chief Executive Officer
Chief Strategy Officer
Head of Research and Development
Chief Financial Officer
Analyst, TD Cowan
Analyst, Kenner Fitzgerald
Analyst, Bank of America
Watch the replay and follow the connected company analysis, news, and investor updates for Novavax, Inc..
WEBVTT 00:00:00.031 -- 00:00:03.413 Thank you for standing by, everyone. My name is Jim, and I'll be your conference operator 00:00:03.413 -- 00:00:08.855 for today. I would like to welcome everyone to the Novavax second quarter 2026 financial 00:00:08.855 -- 00:00:11.737 results and operational highlights conference call. 00:00:11.737 -- 00:00:15.419 All lines have been placed on a mute to prevent any background noise. 00:00:15.419 -- 00:00:18.981 After today's speaker's remarks, there will be a question and answer session. 00:00:18.981 -- 00:00:22.943 If you would like to ask a question during that time, simply press star followed by the 00:00:22.943 -- 00:00:26.965 number one on your telephone keypad. And if you would like to withdraw your question, 00:00:26.965 -- 00:00:30.233 simply press star and one again. Thank you. 00:00:30.233 -- 00:00:33.434 It's now my pleasure to turn the floor over to Naina Zeman. 00:00:33.434 -- 00:00:35.734 You may begin. 00:00:38.456 -- 00:00:43.337 Good morning, and thank you all for joining us today to discuss our second quarter financial 00:00:43.337 -- 00:00:48.728 results and operational highlights today on August 6, 2026. 00:00:48.728 -- 00:00:54.809 A press release announcing our results is available on our website at www.novavax.com 00:00:56.190 -- 00:01:01.772 and an audio archive of this conference call will be available on our website later today. 00:01:01.772 -- 00:01:06.133 Before we begin with prepared remarks, I would like to remind you that this presentation 00:01:06.133 -- 00:01:11.168 includes forward-looking statements regarding Novavax's current expectations 00:01:11.168 -- 00:01:16.389 related to, but not limited to, its partnerships, market opportunities, and financial 00:01:16.389 -- 00:01:21.450 guidance. Our ...